• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Oc­ta­gon Ther­a­peu­tics shuts down af­ter 'un­re­solved bi­ol­o­gy ques­tion­s'

4 weeks ago
People
Startups

Vaxart says it can re­sume next-gen Covid work, will screen par­tic­i­pants for oral vac­cine tri­al

4 weeks ago
Pharma
FDA+

New House bill would cut tax de­duc­tions phar­ma com­pa­nies re­ceive for ads

4 weeks ago
Law

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

4 weeks ago
Pharma
FDA+

WuXi AppTec sees growth af­ter 2024 dip, plans ‘lean’ op­er­a­tions to tem­per ‘ex­ter­nal op­por­tu­ni­ties’

4 weeks ago
China
Pharma

Bio­haven gets an up to $600M in­vest­ment; Prile­nia, Fer­rer make a deal in Eu­rope

4 weeks ago
News Briefing

Schol­ar Rock names new CEO, adds biotech vet­er­ans in C-suite re­build

4 weeks ago
People

Dai­ichi Sankyo says pro­duc­tion boost in US will help cush­ion tar­iff im­pact

4 weeks ago
Pharma
Manufacturing

Boehringer’s up­dat­ed re­sults in HER2-mu­tat­ed lung can­cer im­press

4 weeks ago
R&D

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

4 weeks ago
Deals
Pharma

Eu­ro­pean reg­u­la­tors rec­om­mend new drugs from Ver­tex, Am­gen and Jazz 

4 weeks ago
Pharma
FDA+

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

4 weeks ago
Pharma

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

4 weeks ago
Financing
AI

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

4 weeks ago
R&D
Pharma

Keytru­da around head and neck can­cer surgery cuts chance of dis­ease com­ing back

4 weeks ago
R&D

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

4 weeks ago
R&D

J&J re­ports dura­bil­i­ty da­ta for blad­der can­cer 'pret­zel' drug af­ter FDA fil­ing

5 weeks ago
R&D

Earn­ings sea­son is up­on us; Makary on rare dis­ease; Start­up is first to in­ject CRISPR in the brain; and more

5 weeks ago
Weekly

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

5 weeks ago
R&D
Pharma

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

5 weeks ago
Pharma
Manufacturing

Am­gen in­vests $900M to ex­pand Ohio bio­man­u­fac­tur­ing

5 weeks ago
Manufacturing

Com­pound­ing phar­ma­cies dealt a blow in fight over end of semaglu­tide short­age

5 weeks ago
Pharma
Law

RFK Jr. touts CMS pro­gram test­ing new ways to pay for sick­le cell dis­ease treat­ment

5 weeks ago
Pharma
Cell/Gene Tx

Ake­so shares new da­ta sug­gest­ing it can beat Keytru­da on sur­vival, wins Chi­na ap­proval

5 weeks ago
R&D
China
First page Previous page 9101112131415 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times